Skip to main content
Clinical Trials/DRKS00008869
DRKS00008869
Completed
未知

eurobiological correlates and mechanisms of the augmentation of psychotherapy with endurance exercise in mild to moderate depression - SPeED

Department Sport- und Gesundheitswissenschaften, Sozial- und Präventivmedizin, Universität Potsdam0 sites105 target enrollmentJuly 28, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
F32.0
Sponsor
Department Sport- und Gesundheitswissenschaften, Sozial- und Präventivmedizin, Universität Potsdam
Enrollment
105
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2015
End Date
December 31, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department Sport- und Gesundheitswissenschaften, Sozial- und Präventivmedizin, Universität Potsdam

Eligibility Criteria

Inclusion Criteria

  • The study is conducted with 18\- to 65\- years old, as physical healthy diagnosed ambulant psychotherapy patients with the main diagnosis of a mild to moderate depressive episode diagnosed according to ICD\-10 (F32\.0, F32\.1\), which can also occur in the context of a recurrent depressive disorder (F33\.0, F33\.1\). The presence of a major depressive episode is assured by creating structured clinical interview I for DSM \- IV (SCID I) ; Axis I: mental disorders, depression section.
  • The healthy control group (18\-65 years old).
  • Subjects of the healthy control group are 18\-65 years old and have no major depressive disorder.

Exclusion Criteria

  • Following exclusion criteria are applied: current severe depressive episode with and without psychotic symptoms (F32\.2, F32\.3, F33\.2 or F33\.3\), current borderline or dissocial personality disorder, acute suicide risk, current or lifetime schizophrenia spectrum disorder, delusional disorders (F2x.x), bipolar affective disorder (F31\.x), current dependence (alcohol, heroin, amphetamine, cocaine), minimum period of rest 12 month, current severe neurological diseases and illnesses of central nervous system, severe chronic obstructive pulmonary disease (COPD), coronary heart disease, cardiac insufficiency, anaemia, body mass index \> 35 or \< 18, language problems, non\-correctable hearing and visual impairments, MRI unsuitability, current use of benzodiazepines or beta blockers within the last 7 days, tricyclic antidepressants with a dose of \> 50mg per day, neuroleptics with a dose of \> 30% of the maximum daily dose, regular endurance training (more than two times per week for 45min).

Outcomes

Primary Outcomes

Not specified

Similar Trials